This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Bernstein Liebhard LLP
Bernstein Liebhard LLP is currently offering Pradaxa lawsuit evaluations to patients who allegedly suffered cerebral hemorrhaging, gastrointestinal bleeding and other serious Pradaxa bleeding injuries.
New York, NY (PRWEB) January 20, 2013
Bernstein Liebhard LLP has launched a new Pradaxa lawsuit website dedicated to informing the public about the harmful side effects that may stem from the blood thinner manufactured by Boehringer-Ingelheim Pharmaceuticals Inc. The information provided by the firm’s new Pradaxa website is vital to anyone seeking to file a Pradaxa lawsuit.
Bernstein Liebhard LLP is currently offering free and confidential Pradaxa lawsuit evaluations to patients who have sustained the following injuries:
“We are receiving more and more inquiries from people who claim to have suffered life-threatening Pradaxa bleeding side effects. Our new website will help provide information about potential Pradaxa side effects, as well as updates on the mounting number of Pradaxa lawsuits being filed by people around the U.S.," says Bernstein Liebhard LLP, a nationwide law firm representing the victims of drugs and medical devices.
Pradaxa, a blood thinner prescribed to reduce the risk of stroke and embolism in patients with non-valvular atrial fibrillation, was approved by the U.S. Food and Drug Administration (FDA) in 2010. In 2011, the FDA received reports of 3,781 side effects and 542 deaths tied to the blood thinner, according to a recent article from Bloomberg.com.*
Patients with artificial heart valves were recently found to be at a heightened risk for suffering Pradaxa side effects. Following this revelation, the FDA issued a public health communication on December 19, 2012 informing health care providers and the public that Pradaxa should not be used to prevent stroke or blood clots in patients with mechanical heart valves. The agency also announced that all health care providers would be receiving “Dear Doctor Letters” from the company alerting them of this change.**
A number of Pradaxa lawsuits have already been filed on behalf of patients who experienced side effects associated with the drug. These Pradaxa lawsuits have since been consolidated into the multidistrict litigation, In re: Pradaxa Product Liability Litigation (“MDL No. 2385”) underway in the U.S. District Court for the Southern District of Illinois and are pending before Judge David R. Herndon. According to a report in the Madison Record, 176 Pradaxa lawsuits were pending in this MDL as of Jan. 10, 2013.***
Patients who took Pradaxa and suffered excessive bleeding side effects may be entitled to file a Pradaxa lawsuit to receive compensation for lost wages, medical expenses, as well as any pain and suffering they may have been caused as a result of their injury. Learn more about Pradaxa side effects by visiting Bernstein Liebhard LLP’s website, http://www.consumerinjurylawyers.com/ or by contacting a lawyer at Bernstein Liebhard LLP today at (877) 779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpradaxa-lawsuit/pradaxa-bleeding/prweb10340318.htm